Physician profile
James Cai
NPI 1215331152
$7,292.32
in general payments reported to CMS, 2019-2025
36 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $890 · 2022: $1,179 · 2023: $1,768 · 2024: $1,744 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,223.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $997.82 | 2021-2025 | Nexletol, Nexlizet |
| Abbvie INC. | $936.62 | 2022-2025 | |
| Amgen INC. | $798.44 | 2021-2025 | Repatha, Evenity, Repatha |
| Astrazeneca Pharmaceuticals Lp | $658.18 | 2021-2025 | Farxiga, Lokelma, Breztri |
| Glaxosmithkline, LLC. | $590.37 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $381.91 | 2021-2023 | Xarelto |
| Gilead Sciences, INC. | $323.42 | 2022-2025 | |
| Novo Nordisk INC | $318.60 | 2021-2025 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $233.27 | 2022-2024 | |
| Pfizer INC. | $197.33 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $183.43 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $169.83 | 2023-2025 | |
| Lilly USA, LLC | $156.29 | 2022-2025 | Jardiance, Mounjaro, Kisunla |
| Terumo Medical Corporation | $143.33 | 2023 | Angio-Seal, Glidesheath Slender |
| Phathom Pharmaceuticals, INC. | $125.42 | 2024 | Voquezna |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.